NOW OPEN: Now Accepting Abstracts for dedicated sessions devoted to Late Breaking Trials and Novel Technology and Emerging Studies!!
As the leading scientific venous meeting, the AVF is soliciting abstracts for 2 dedicated sessions to be considered for podium presentations during AVF 2026:
- Late Breaking Trials – Abstracts of clinical trials that will present results of prospective studies, preferably multicenter (5 centers or more). Trials that are ongoing but expect to have results at the time of presentation are allowed. Specification of the number of patients or procedures expected to be reported on and the outcomes that will be presented should be included in the abstract. Priority will be given to abstracts that contain preliminary data.
- Novel Technology and Emerging Studies – Abstracts of ongoing trials that do not have results and are not expected to present data during Venous 2025. Novel technology that is in development is allowed. Abstracts of novel technology should contain the indications for use and the mechanism of action. Abstracts of emerging studies should describe in detail patient recruitment plan, projected enrollment, indications, inclusion and exclusion criteria. Priority will be given to clinical trials in the first year of enrollment and technology that is in early commercialization phase.
- Retrospective analyses and studies that do not meet these criteria will not be considered as they have already been evaluated during the regular abstract submission process.
For questions regarding the AVF 38th Annual Meeting, contact AVF at 855-836-6871 or [email protected]
Abstracts for the Main Meeting are now closed
Abstracts for the Main Meeting are now closed.
Deadline closed on August 25, 2025
AVF only accepts electronic abstract submissions via the official abstract submission website.
ALL presenters MUST be paid registrants and must complete all necessary forms and disclosures to present.
Acceptance of abstract will be considered a commitment to present in person at the AVF 2026 Annual Meeting in Denver, Colorado, March 1-4.
Prizes for Winning Abstracts!
The best 2 abstract presentations and the best 2 poster presentations will be formally recognized with prizes in person at the AVF 2026 Annual Meeting.
ABSTRACT GUIDELINES
- All work submitted to the AVF 2026 Annual Meeting must be original and not previously published or presented. All work at the time of presentation at the Annual Meeting must also be original. All authors must attest that the presentations given at the meeting have never been presented or published before the date of presentation at the AVF Annual Meeting. Those found to be in violation of this policy will be prohibited from presenting at the AVF Annual Meeting for the next two years.
- Titles need to be submitted in Title Case (Not ALL CAPS and not Sentence case).
- Abstract length is 425 words or less, excluding title and authors.
- Each table and/or graph will count as 25 words in the total word count. (Limit two images per abstract). If you do upload a table or graph it is mandatory that it has a title, and the table or graph is referenced in the abstract components section.
- All uploads (tables/graphs) must be cited within the abstract text.
- All uploads must be in jpeg or png format ONLY.
- Three presentation types will be offered, you will need to select one: Oral Presentation, Quick Shot Presentation, or Poster Presentation. Your presentation will be given every consideration for the category selected; however, the final determination will be made by the Program Committee.
- The following submission categories will be offered, you will need to select the one that best fits your abstract: Basic Science, Diagnostic Testing and Imaging, Superficial Vein Disease, Chronic Deep Venous Disease (Obstruction/Reflux), Pelvic Venous Disease, Venous Thromboembolism/IVC Filters, Lymphedema, Wound Care, Vascular Medicine, Venous Healthcare Inequities and Miscellaneous.
- Abstracts must be submitted with 4 components: Background, Methods, Results, and Conclusion.
- No reference should be made in the abstract to the names or institutions of the authors.
- All accepted Oral Presentations will be published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL).
- Abstract presenters that are selected for a podium presentation are encouraged to submit a manuscript for consideration to the JVS-VL. To assist with the Article Processing Charge (APC), AVF members receive a 20% discount on the fee. In addition, for our members, the AVF will cover 50% of that reduced fee. For authors who are also a member of the SVS, the SVS will cover the other 50% of the fee.
- Announcements of accepted and rejected abstracts will be made in late October.
- Complete instructions for presentations will be provided with your notification of acceptance.
- Abstracts must be submitted in English.
- ALL presenting authors ARE REQUIRED to register/pay for their attendance at the meeting (full meeting registration, based on your AVF membership status).
For questions regarding the AVF 38th Annual Meeting, contact AVF at 855-836-6871 or [email protected]
Deadline closed on August 25, 2025
Abstracts for the Advanced Practice Provider (APP) Sessions are now closed
Abstracts for the Advanced Practice Provider (APP) Sessions are now closed.
The deadline was September 15, 2025.
AVF only accepts electronic abstract submissions via the official abstract submission website.
ALL presenters MUST be paid registrants and must complete all necessary forms and disclosures to present.
Acceptance of abstract will be considered a commitment to present in person at the AVF 2026 Annual Meeting in Denver, Colorado, during the APP Pre-meeting being held February 28-March 1.
Prize for Winning Abstract!
The best abstract presentation will be formally recognized with a prize in person.
ABSTRACT GUIDELINES
- All work submitted to the AVF 2026 Annual Meeting must be original and not previously published or presented. All work at the time of presentation at the Annual Meeting must also be original. All authors must attest that the presentations given at the meeting have never been presented or published before the date of presentation at the AVF Annual Meeting. Those found to be in violation of this policy will be prohibited from presenting at the AVF Annual Meeting for the next two years.
- Titles need to be submitted in Title Case (Not ALL CAPS and not Sentence case).
- Abstract length is 425 words or less, excluding title and authors.
- Each table and/or graph will count as 25 words in the total word count. (Limit two images per abstract). If you do upload a table or graph it is mandatory that it has a title, and the table or graph is referenced in the abstract components section.
- All uploads (tables/graphs) must be cited within the abstract text.
- All uploads must be in jpeg or png format ONLY.
- Two presentation types will be offered, you will need to select one: Oral Presentation or Quick Shot Presentation. Your presentation will be given every consideration for the category selected; however, the final determination will be made by the APP Program Committee.
- The following submission categories will be offered, you will need to select the one that best fits your abstract: Basic Science, Diagnostic Testing and Imaging, Superficial Vein Disease, Chronic Deep Venous Disease (Obstruction/Reflux), Pelvic Venous Disease, Venous Thromboembolism/IVC Filters, Lymphedema, Wound Care, Vascular Medicine, Venous Healthcare Inequities and Miscellaneous.
- Abstracts must be submitted with 4 components: Background, Methods, Results, and Conclusion.
- No reference should be made in the abstract to the names or institutions of the authors.
- All accepted Oral Presentations will be published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL).
- Announcements of accepted and rejected abstracts will be made in late October.
- Complete instructions for presentations will be provided with your notification of acceptance.
- Abstracts must be submitted in English.
- ALL presenting authors ARE REQUIRED to register/pay for their attendance at the meeting (full meeting registration, based on your AVF membership status).
For questions regarding the AVF 38th Annual Meeting, contact AVF at 855-836-6871 or [email protected]
The deadline was September 15, 2025.
